Market Closed -
OTC Markets
20:53:34 09/05/2024 BST
5-day change
1st Jan Change
0.000001
USD
0.00%
0.00%
-99.95%
Fiscal Period: December
2017
2018
2019
2020
2021
2022
Capitalization
1
238.8
232.6
146.8
206.6
100.2
30.6
Enterprise Value (EV)
2
230.4
227.3
142.5
170.5
81.25
38.28
P/E ratio
-19.2
x
-10.3
x
-5.26
x
-5.33
x
-2.47
x
-0.53
x
Yield
-
-
-
-
-
-
Capitalization / Revenue
-
2,837,182,512
x
2,488,635,983
x
68,882,701,000
x
-
-
EV / Revenue
-
2,771,975,195
x
2,415,805,475
x
56,823,701,000
x
-
-
EV / EBITDA
-20.7
x
-11.3
x
-5.43
x
-4.29
x
-2.1
x
-0.97
x
EV / FCF
-42.3
x
-18.9
x
-7.97
x
-6.95
x
-3.68
x
-1.78
x
FCF Yield
-2.36%
-5.3%
-12.5%
-14.4%
-27.2%
-56.2%
Price to Book
38
x
54
x
22.8
x
5.25
x
4.65
x
-3.52
x
Nbr of stocks (in thousands)
3,991
4,500
5,063
6,709
8,214
12,593
Reference price
3
59.84
51.70
29.00
30.80
12.20
2.430
Announcement Date
20/03/18
21/03/19
30/03/20
17/03/21
17/03/22
16/03/23
1 USD in Million 2 CAD in Million 3 USD
Fiscal Period: December
2017
2018
2019
2020
2021
2022
Net sales
-
0.082
0.059
0.003
-
-
EBITDA
1
-11.11
-20.1
-26.26
-39.77
-38.78
-39.58
EBIT
1
-11.25
-20.33
-26.64
-40.12
-39.1
-40.27
Operating Margin
-
-24,795.12%
-45,144.07%
-1,337,233.33%
-
-
Earnings before Tax (EBT)
1
-12.03
-21.94
-27.36
-34.86
-36.59
-37.99
Net income
1
-12.03
-21.94
-27.36
-34.86
-36.59
-37.99
Net margin
-
-26,750%
-46,381.36%
-1,161,833.33%
-
-
EPS
2
-3.112
-5.012
-5.511
-5.780
-4.931
-4.553
Free Cash Flow
1
-5.449
-12.06
-17.88
-24.52
-22.11
-21.51
FCF margin
-
-14,702.59%
-30,300.42%
-817,287.5%
-
-
FCF Conversion (EBITDA)
-
-
-
-
-
-
FCF Conversion (Net income)
-
-
-
-
-
-
Dividend per Share
-
-
-
-
-
-
Announcement Date
20/03/18
21/03/19
30/03/20
17/03/21
17/03/22
16/03/23
Fiscal Period: December
2020 Q3
2020 Q4
2021 Q1
2021 Q2
2021 Q3
2021 Q4
2022 Q1
2022 Q2
2022 Q3
2022 Q4
Net sales
1
0.088
0.089
0.0834
0.0526
0.051
0.0446
0.0312
0.0434
0.1578
0.2111
EBITDA
1
-8.468
-10.27
-8.49
-9.15
-12.83
-14.57
-13.08
-12.41
-11.7
-14.67
EBIT
1
-8.415
-10.36
-8.49
-9.304
-12.91
-14.35
-13.31
-12.69
-12.1
-12.35
Operating Margin
-9,562.5%
-11,643.82%
-10,182.14%
-17,674.73%
-25,311.33%
-32,182.04%
-42,578.4%
-29,246.54%
-7,670.55%
-5,848.39%
Earnings before Tax (EBT)
1
-8.327
-9.596
-8.406
-9.323
-12.98
-14.95
-13.7
-12.64
-11.95
-11.91
Net income
1
-8.327
-9.596
-8.406
-9.323
-12.98
-14.95
-13.7
-12.64
-11.95
-11.91
Net margin
-9,462.5%
-10,782.02%
-10,082.14%
-17,710.45%
-25,460.12%
-33,527.6%
-43,845.06%
-29,134.79%
-7,570.55%
-5,639.24%
EPS
2
-1.300
-1.400
-1.210
-1.376
-1.617
-1.770
-1.681
-1.531
-1.471
-1.311
Dividend per Share
-
-
-
-
-
-
-
-
-
-
Announcement Date
12/11/20
17/03/21
12/05/21
11/08/21
10/11/21
17/03/22
13/05/22
11/08/22
10/11/22
16/03/23
Fiscal Period: December
2017
2018
2019
2020
2021
2022
Net Debt
1
-
-
-
-
-
7.67
Net Cash position
1
8.37
5.35
4.3
36.2
19
-
Leverage (Debt/EBITDA)
-
-
-
-
-
-0.1939
x
Free Cash Flow
1
-5.45
-12.1
-17.9
-24.5
-22.1
-21.5
ROE (net income / shareholders' equity)
-181%
-412%
-508%
-152%
-140%
-509%
ROA (Net income/ Total Assets)
-43.8%
-63.6%
-73.4%
-61.7%
-50.8%
-61.8%
Assets
1
27.48
34.49
37.28
56.46
71.96
61.49
Book Value Per Share
2
1.570
0.9600
1.270
5.870
2.620
-0.6900
Cash Flow per Share
2
3.700
3.300
2.780
6.910
4.700
2.220
Capex
1
0.39
2.19
0.48
0.44
1.4
1.07
Capex / Sales
-
2,664.63%
806.78%
14,733.33%
-
-
Announcement Date
20/03/18
21/03/19
30/03/20
17/03/21
17/03/22
16/03/23
1st Jan change
Capi.
-99.95% 11 +29.77% 49.46B +1.00% 42.58B +49.28% 42.49B -5.26% 29.09B +13.68% 26.61B -22.99% 18.64B +8.22% 13.16B +32.41% 12.55B +24.01% 12.1B
Other Biotechnology & Medical Research
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
marketscreener.com**derivatives**en**/dynamic-chart/**Premium**Expert**Access**Annual**Monthly**The best tools reserved for subscribers to boost the performance of your investments!**#ffffff**/registration/member/**#004eff**#000000**Optimize my profits**1**
#252525**Blanc**7**To continue browsing, please register!**#ffffff50**14px**#33d251**